Aug 14 (Reuters) - Prima BioMed Ltd PRR.AX :
* Milestone payment to be received from Novartis PRR.AX
* Will receive undisclosed clinical milestone payment from its collaboration and licensing agreement with Novartis
* Says agreement with Novartis relating to its phase i imp701 lag-3 antibody
* Source text (http://bit.ly/1gEXnjt)